Generation of Dendritic cells from patients with breast cancer, multiple myeloma or ovarian cancer

Recruiting

• Conditions: Breast Cancer; Multiple Myeloma; Ovarian Cancer; 10018865; 10006291

• Registration Number: NL-OMON33883
• Lead Sponsor: niversitair Medisch Centrum Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 9

Inclusion Criteria

patients with either breast cancer, ovarian cancer or Multiple Myeloma, that did not receive any systemic therapy during the previous three months. (Hormonal therapy is accepted in case of breast cancer). For details of inclusion: see paragraph D4b.

Exclusion Criteria

Recent (3 months) systemic therapy. In more detail: see D5b.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Can we collect enough and adequate dendritic cells from the group of patients<br /><br>defined above, in our facility and using our culture system.<br /><br>For clarity: there will be no add back of the cells to patients in this study</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not relevant.</p><br>